South Korea · Delayed Price · Currency is KRW Instructure Holdings Statistics
Total Valuation
HLB SCIENCE has a market cap or net worth of KRW 24.37 billion.
| Market Cap | 24.37B |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HLB SCIENCE has 17.84 million shares outstanding.
| Current Share Class | 17.84M |
| Shares Outstanding | 17.84M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.43% |
| Owned by Institutions (%) | n/a |
| Float | 4.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.92 |
| P/TBV Ratio | 4.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.12
| Current Ratio | 12.12 |
| Quick Ratio | 11.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -250.59 |
Financial Efficiency
Return on equity (ROE) is -70.30% and return on invested capital (ROIC) is -44.89%.
| Return on Equity (ROE) | -70.30% |
| Return on Assets (ROA) | -40.76% |
| Return on Invested Capital (ROIC) | -44.89% |
| Return on Capital Employed (ROCE) | -41.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.73% in the last 52 weeks. The beta is 0.13, so HLB SCIENCE's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -39.73% |
| 50-Day Moving Average | 1,346.02 |
| 200-Day Moving Average | 1,774.62 |
| Relative Strength Index (RSI) | 44.80 |
| Average Volume (20 Days) | 19,317 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -60,000 |
| Operating Income | -2.60B |
| Pretax Income | -2.55B |
| Net Income | -2.55B |
| EBITDA | -2.42B |
| EBIT | -2.60B |
| Earnings Per Share (EPS) | -566.00 |
Balance Sheet
The company has 5.84 billion in cash and n/a in debt, giving a net cash position of 5.84 billion or 327.13 per share.
| Cash & Cash Equivalents | 5.84B |
| Total Debt | n/a |
| Net Cash | 5.84B |
| Net Cash Per Share | 327.13 |
| Equity (Book Value) | 6.21B |
| Book Value Per Share | 1,380.37 |
| Working Capital | 5.83B |
Cash Flow
In the last 12 months, operating cash flow was -2.19 billion and capital expenditures -202.32 million, giving a free cash flow of -2.39 billion.
| Operating Cash Flow | -2.19B |
| Capital Expenditures | -202.32M |
| Free Cash Flow | -2.39B |
| FCF Per Share | -134.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HLB SCIENCE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -10.45% |
| FCF Yield | -9.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 6, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Apr 6, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |